| CFS patients | Healthy controls |
---|---|---|
Dependent variable: plasma norepinephrine | ||
 R squared | 0.015 | 0.043 |
 Plasma epinephrine | ||
  Regression coefficient, B (95 % CI) | 0.82 (−0.38 to 2.02) | 1.19 (−0.19 to 2.58) |
  p value | 0.179 | 0.090 |
Dependent variable: urine norepinephrine:creatinine ratio | ||
 R squared | 0.009 | 0.114 |
 Plasma norepinephrine | ||
  Regression coefficient, B (95 % CI) | 4.8 (−4.6 to 14) × 10−5 | 35 (11–59) × 10−5 |
  p value | 0.314 | 0.005 |
Dependent variable: plasma epinephrine | ||
 R squared | 0.015 | 0.043 |
 Plasma norepinephrine | ||
  Regression coefficient, B (95 % CI) | 0.02 (−0.01 to 0.05) | 0.04 (−0.01 to 0.08) |
  p value | 0.179 | 0.090 |
Dependent variable: urine epinephrine:creatinine ratio | ||
 R squared | 0.028 | 0.000 |
 Plasma epinephrine | ||
  Regression coefficient, B (95 % CI) | 88 (−7 to 182) × 10−5 | −11 (−221 to 199) × 10−5 |
  p value | 0.069 | 0.917 |
Dependent variable: plasma cortisol | ||
 R squared | 0.184 | 0.184 |
 Plasma ACTH | ||
  Regression coefficient, B (95 % CI) | 25.3 (13.4–37.2) | 15.3 (1.1–29.6) |
  p value | <0.001 | 0.036 |
 Plasma TSH | ||
  Regression coefficient, B (95 % CI) | 12.7 (−9.4 to 35.0) | 26.7 (1.1–52.4) |
  p value | 0.262 | 0.041 |
 Plasma FT4 | ||
  Regression coefficient, B (95 % CI) | 17.0 (6.0–28.0) | −4.9 (−24.2 to 14.4) |
  p value | 0.003 | 0.613 |
Dependent variable: urine cortisol:creatinine ratio | ||
 R squared | 0.058 | 0.016 |
 Plasma cortisol | ||
  Regression coefficient, B (95 % CI) | −11 (−19 to −3.0) × 10−4 | −7 (−20 to 6.8) × 10−4 |
  p value | 0.008 | 0.311 |